Dozens of New Genes Associated With Cancer Treatment Resistance Are Identified
Using a CRISPR gene editing technique, researchers have identified dozens of new genes that create T-cell resistant cancer.
Newly Identified Genetic Mutations found in Ashkenazi Jewish Women with Breast Cancer
Comprehensive sequencing for all breast cancer genes may provide complete relevant genetic information for Ashkenazi Jewish patients.
New Genetic Mutations Linked to Breast and Ovarian Cancers
Researchers have discovered new associations between breast and ovarian cancer and genes that had not been previously detected, and which may help guide treatment decisions in the future.
Anti-Leukemic Drug Gemtuzumab Ozogamicin May Benefit Some AML Patients
A new study in JCO suggests that genetic variations within AML patients with CD33 may predict their response to gemtuzumab ozogamicin.
New Study Questions Guidelines for Genetic Screening for Prostate Cancer
Men with prostate cancer and one additional primary cancer may harbor a mutation in a cancer-predisposing gene, but the majority of these men do not meet criteria for clinical genetic testing.
Tissue-Resident Memory Cells Associated with Cytotoxic T Cell Responses
A subpopulation of T cells called tissue resident memory cells may be able to determine which cancer patients' immune systems can mount an effective anti-tumor response
TAPUR Trial Leverages Genomic Testing for Precision Medicine
In this video, Dr. Edward Kim provides details on the TAPUR trial, which uses broad genomic test results to aid in precision medicine for cancer patients.
Better Research Efforts Needed Among Racial/Ethnic Population
Dr. Bobby Lazzara highlights a recent study published in JAMA Oncology on ethnic/racial disparity in genome sequencing and how researchers may be leaving this population behind.
The Illinois Precision Medicine Initiative Cohort Program to Enroll Participants
The University of Illinois at Chicago, Northwestern University, the University of Chicago, and other affiliated hospitals and clinics have been selected to enroll 150,000 Illinoisans in the national Precision Medicine Initiative Cohort Program.
Shorter Turnaround Time for BRAF Mutation Testing
Obtaining blood biopsies instead of invasive tissue biopsies may be less risky for patients, faster, and cost less.
Slide Show: Trends in Targeted Therapies and Immunotherapies
This slide show provides information on the present and future of targeted therapies and immunotherapies based on a report from the IMS Institute for Healthcare Informatics.
By clicking Accept, you agree to become a member of the UBM Medica Community.